EX-3.3 4 v450899_ex3-3.htm EXHIBIT 3.3

 

 

    CERTIFIED COPY
    Of a Document filed with the Province of
British Columbia Registrar of Companies
     
   
    CAROL PREST
 

 

Notice of Articles

BUSINESS CORPORATIONS ACT

 

 

 

 

 

This Notice of Articles was issued by the Registrar on: October 21, 2016 10:19 AM Pacific Time

 

Incorporation Number:   C1093896

 

Recognition Date and Time: Continued into British Columbia on October 21, 2016 10:19 AM Pacific Time

 

 

 

NOTICE OF ARTICLES

 

Name of Company:

 

CYNAPSUS THERAPEUTICS INC.

  

   
REGISTERED OFFICE INFORMATION  
Mailing Address: Delivery Address:
1600 - 925 WEST GEORGIA STREET 1600 - 925 WEST GEORGIA STREET
VANCOUVER BC V6C 3L2 CANADA VANCOUVER BC V6C 3L2 CANADA

 

   
RECORDS OFFICE INFORMATION  
Mailing Address: Delivery Address:
1600 - 925 WEST GEORGIA STREET 1600 - 925 WEST GEORGIA STREET
VANCOUVER BC V6C 3L2 CANADA VANCOUVER BC V6C 3L2 CANADA

 

 

 

  

DIRECTOR INFORMATION

 

Last Name, First Name, Middle Name:

Bokar, Gregory M.

 

Mailing Address: Delivery Address:
84 WATERFORD DRIVE 84 WATERFORD DRIVE

MARLBOROUGH MA 01752

UNITED STATES

MARLBOROUGH MA 01752
UNITED STATES

 

Last Name, First Name, Middle Name:

Reynolds, Douglas

 

Mailing Address: Delivery Address:
6790 CENTURY AVENUE, SUITE 100
MISSISSAUGA ON L5N 2V8
CANADA
6790 CENTURY AVENUE, SUITE 100
MISSISSAUGA ON L5N 2V8
CANADA

  

Last Name, First Name, Middle Name:

Freeman, Stephen L.

 

Mailing Address: Delivery Address:
84 WATERFORD DRIVE 84 WATERFORD DRIVE

MARLBOROUGH MA 01752

UNITED STATES

MARLBOROUGH MA 01752
UNITED STATES

 

 

AUTHORIZED SHARE STRUCTURE

 

 

 

  1. No Maximum Common Shares Without Par Value
         
        Without Special Rights or
Restrictions attached

 

 

 

 

 

   
  Continuation
Application
CERTIFIED COPY
Of a Document filed with the Province of
British Columbia Registrar of Companies
     
 

FORM 16

BUSINESS CORPORATIONS ACT

Section 302

 

    CAROL PREST

 

 

FILING DETAILS: Continuation Application for:
  CYNAPSUS THERAPEUTICS INC.
   
  Incorporation Number: C1093896
   
   
Filed Date and Time: October 21, 2016 10:19 AM Pacific Time
   
   
Recognition Date and Time: Continued into British Columbia October 21, 2016 10:19 AM Pacific Time

 

  

 

 

 

CONTINUATION APPLICATION

 

 

 

 

Name Reservation Number:   Name Reserved:
NR4820973   CYNAPSUS THERAPEUTICS INC.

  

     
PREVIOUS FOREIGN JURISDICTION INFORMATION    
     
Identifying Number in Foreign Jurisdiction:   Name in Foreign Jurisdiction:
     
955505-6   Cynapsus Therapeutics Inc.
     
Date of Incorporation, Continuation, or Amalgamation in Foreign Jurisdiction:   Foreign Jurisdiction:
     
     
January 01, 2016   FEDERAL

 

 

 

 

Authorization for Continuation

The authorization for the continuation into BC from the foreign corporations jurisdiction was filed.

 

 

 

NOTICE OF ARTICLES

 

Name of Company:

CYNAPSUS THERAPEUTICS INC.

  

   
REGISTERED OFFICE INFORMATION  
Mailing Address: Delivery Address:
1600 - 925 WEST GEORGIA STREET 1600 - 925 WEST GEORGIA STREET
VANCOUVER BC V6C 3L2 CANADA VANCOUVER BC V6C 3L2 CANADA

 

   
RECORDS OFFICE INFORMATION  
Mailing Address: Delivery Address:
1600 - 925 WEST GEORGIA STREET 1600 - 925 WEST GEORGIA STREET
VANCOUVER BC V6C 3L2 CANADA VANCOUVER BC V6C 3L2 CANADA

 

 

DIRECTOR INFORMATION

 

Last Name, First Name, Middle Name:

Bokar, Gregory M.

 

Mailing Address: Delivery Address:
84 WATERFORD DRIVE 84 WATERFORD DRIVE

MARLBOROUGH MA 01752

UNITED STATES

MARLBOROUGH MA 01752
UNITED STATES

 

Last Name, First Name, Middle Name:

Reynolds, Douglas

 

Mailing Address: Delivery Address:
6790 CENTURY AVENUE, SUITE 100
MISSISSAUGA ON L5N 2V8
CANADA
6790 CENTURY AVENUE, SUITE 100
MISSISSAUGA ON L5N 2V8
CANADA

  

Last Name, First Name, Middle Name:

Freeman, Stephen L.

 

Mailing Address: Delivery Address:
84 WATERFORD DRIVE 84 WATERFORD DRIVE

MARLBOROUGH MA 01752

UNITED STATES

MARLBOROUGH MA 01752
UNITED STATES

 

 

 

 

 

 

AUTHORIZED SHARE STRUCTURE

 

 

 

  1. No Maximum Common Shares Without Par Value
         
        Without Special Rights or
Restrictions attached